Literature DB >> 7771614

Evaluation of the severe combined immunodeficient (SCID) mouse as an animal model for dengue viral infection.

S J Wu1, C G Hayes, D R Dubois, M G Windheuser, Y H Kang, D M Watts, D G Sieckmann.   

Abstract

Severe combined immunodeficient (SCID) mice reconstituted with human peripheral blood lymphocytes (hu-PBL) were evaluated as an animal model for demonstrating dengue (DEN) viral infection. Reconstituted mice (hu-PBL-SCID) that demonstrated successful engraftment by the presence of serum titers of human immunoglobulin (Ig) were inoculated intraperitoneally with DEN virus serotype 1 (DEN-1). Serial blood samples were taken postinoculation and assayed for virus in C6/36 cells. The identity of all viral isolates was confirmed by an immunofluorescence antibody assay using DEN-1 monoclonal antibody. A total of six experiments were performed using different procedures of reconstitution and infection, and in three of these experiments, DEN-1 virus was recovered from the hu-PBL-SCID mice. In the first successful experiment, DEN-1 virus was recovered on postinoculation day (PID) 24 from blood, spleen, thymus, and lung tissues of one of eight hu-PBL-SCID mice. A second group of eight hu-PBL-SCID mice were inoculated with human monocytes infected in vitro with DEN-1 virus. Virus was recovered from the blood of mice between PID 15 and 23, and from lung tissue of one of these mice. In a third experiment, seven SCID mice were treated initially with anti-asialo GM1 antibody to eliminate natural killer cells, and then were injected simultaneously with a mixture of hu-PBL and DEN-1 virus. Virus was demonstrated in the blood of one mouse on PID 38, and in another mouse on PID 8, 12, 20, 24, and 36.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7771614     DOI: 10.4269/ajtmh.1995.52.468

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  25 in total

Review 1.  Perspectives for the treatment of infections with Flaviviridae.

Authors:  P Leyssen; E De Clercq; J Neyts
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  Mouse STAT2 restricts early dengue virus replication.

Authors:  Joseph Ashour; Juliet Morrison; Maudry Laurent-Rolle; Alan Belicha-Villanueva; Courtney Ray Plumlee; Dabeiba Bernal-Rubio; Katherine L Williams; Eva Harris; Ana Fernandez-Sesma; Christian Schindler; Adolfo García-Sastre
Journal:  Cell Host Microbe       Date:  2010-11-18       Impact factor: 21.023

3.  Potential of ancestral sylvatic dengue-2 viruses to re-emerge.

Authors:  Nikos Vasilakis; Elisabeth J Shell; Eric B Fokam; Peter W Mason; Kathryn A Hanley; D Mark Estes; Scott C Weaver
Journal:  Virology       Date:  2006-10-02       Impact factor: 3.616

Review 4.  Mouse models of dengue virus infection for vaccine testing.

Authors:  Vanessa V Sarathy; Gregg N Milligan; Nigel Bourne; Alan D T Barrett
Journal:  Vaccine       Date:  2015-10-23       Impact factor: 3.641

5.  A mouse-passaged dengue virus strain with reduced affinity for heparan sulfate causes severe disease in mice by establishing increased systemic viral loads.

Authors:  Tyler R Prestwood; Daniil M Prigozhin; Kristin L Sharar; Raphaël M Zellweger; Sujan Shresta
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

6.  A non mouse-adapted dengue virus strain as a new model of severe dengue infection in AG129 mice.

Authors:  Grace K Tan; Jowin K W Ng; Scott L Trasti; Wouter Schul; George Yip; Sylvie Alonso
Journal:  PLoS Negl Trop Dis       Date:  2010-04-27

7.  New mouse model for dengue virus vaccine testing.

Authors:  A J Johnson; J T Roehrig
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

Review 8.  Mouse models of dengue virus infection and disease.

Authors:  Lauren E Yauch; Sujan Shresta
Journal:  Antiviral Res       Date:  2008-07-09       Impact factor: 5.970

9.  Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rgammanull mice.

Authors:  Smita Jaiswal; Todd Pearson; Heather Friberg; Leonard D Shultz; Dale L Greiner; Alan L Rothman; Anuja Mathew
Journal:  PLoS One       Date:  2009-10-05       Impact factor: 3.240

10.  Of mice and humans: how good are HLA transgenic mice as a model of human immune responses?

Authors:  Maya F Kotturi; Erika Assarsson; Bjoern Peters; Howard Grey; Carla Oseroff; Valerie Pasquetto; Alessandro Sette
Journal:  Immunome Res       Date:  2009-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.